231 related articles for article (PubMed ID: 27911311)
1. Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data.
Sennik S; Schweizer TA; Fischer CE; Munoz DG
J Alzheimers Dis; 2017; 55(4):1519-1528. PubMed ID: 27911311
[TBL] [Abstract][Full Text] [Related]
2. Pathological Correlations of Neuropsychiatric Symptoms in Institutionalized People with Dementia.
Esteban de Antonio E; López-Álvarez J; Rábano A; Agüera-Ortiz L; Sánchez-Soblechero A; Amaya L; Portela S; Cátedra C; Olazarán J
J Alzheimers Dis; 2020; 78(4):1731-1741. PubMed ID: 33185596
[TBL] [Abstract][Full Text] [Related]
3. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic differences based on staging of Alzheimer's neuropathology in autopsy-confirmed dementia with Lewy bodies.
Peavy GM; Edland SD; Toole BM; Hansen LA; Galasko DR; Mayo AM
Parkinsonism Relat Disord; 2016 Oct; 31():72-78. PubMed ID: 27475955
[TBL] [Abstract][Full Text] [Related]
5. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
Wilcock GK; Ballard CG; Cooper JA; Loft H
J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023
[TBL] [Abstract][Full Text] [Related]
6. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
[TBL] [Abstract][Full Text] [Related]
7. Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms.
Naasan G; Shdo SM; Rodriguez EM; Spina S; Grinberg L; Lopez L; Karydas A; Seeley WW; Miller BL; Rankin KP
Brain; 2021 Apr; 144(3):999-1012. PubMed ID: 33501939
[TBL] [Abstract][Full Text] [Related]
8. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.
Ballard CG; Jacoby R; Del Ser T; Khan MN; Munoz DG; Holmes C; Nagy Z; Perry EK; Joachim C; Jaros E; O'Brien JT; Perry RH; McKeith IG
Am J Psychiatry; 2004 May; 161(5):843-9. PubMed ID: 15121649
[TBL] [Abstract][Full Text] [Related]
9. Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.
Fischer CE; Qian W; Schweizer TA; Millikin CP; Ismail Z; Smith EE; Lix LM; Shelton P; Munoz DG
J Alzheimers Dis; 2016; 50(1):283-95. PubMed ID: 26682680
[TBL] [Abstract][Full Text] [Related]
10. The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.
Kim J; Schweizer TA; Fischer CE; Munoz DG
J Alzheimers Dis; 2017; 55(1):381-389. PubMed ID: 27662301
[TBL] [Abstract][Full Text] [Related]
11. The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders.
Shaw JS; Leoutsakos JM; Rosenberg PB
Am J Geriatr Psychiatry; 2024 Jun; 32(6):754-764. PubMed ID: 38296755
[TBL] [Abstract][Full Text] [Related]
12. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study.
Treiber KA; Lyketsos CG; Corcoran C; Steinberg M; Norton M; Green RC; Rabins P; Stein DM; Welsh-Bohmer KA; Breitner JC; Tschanz JT
Int Psychogeriatr; 2008 Jun; 20(3):538-53. PubMed ID: 18289451
[TBL] [Abstract][Full Text] [Related]
13. Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study.
de Mauleon A; Soto M; Ousset PJ; Nourhashemi F; Lepage B; Vellas B
Int Psychogeriatr; 2019 Oct; 31(10):1509-1516. PubMed ID: 30714541
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
Shea YF; Ha J; Chu LW
Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
[TBL] [Abstract][Full Text] [Related]
15. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
Qian W; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
[TBL] [Abstract][Full Text] [Related]
16. Neuropathological correlates of neuropsychiatric symptoms in dementia.
Gibson LL; Grinberg LT; Ffytche D; Leite REP; Rodriguez RD; Ferretti-Rebustini REL; Pasqualucci CA; Nitrini R; Jacob-Filho W; Aarsland D; Suemoto CK
Alzheimers Dement; 2023 Apr; 19(4):1372-1382. PubMed ID: 36150075
[TBL] [Abstract][Full Text] [Related]
17. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
[TBL] [Abstract][Full Text] [Related]
18. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
19. The course of neuropsychiatric symptoms in dementia: a 3-year longitudinal study.
Brodaty H; Connors MH; Xu J; Woodward M; Ames D;
J Am Med Dir Assoc; 2015 May; 16(5):380-7. PubMed ID: 25687925
[TBL] [Abstract][Full Text] [Related]
20. Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study.
Nagata T; Shinagawa S; Nakajima S; Plitman E; Mihashi Y; Hayashi S; Mimura M; Nakayama K
J Alzheimers Dis; 2016; 50(3):839-45. PubMed ID: 26836181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
